A naukri.com initiative
Bioengineer
2w
408
Image Credit: Bioengineer
New Homocamptothecin Boosts Pancreatic Cancer Radiotherapy
- Researchers have introduced a new radiosensitizing agent, TOP-0618, derived from homocamptothecin, showing promise in enhancing radiotherapy outcomes for pancreatic cancer according to a study in BMC Cancer.
- Pancreatic cancer poses challenges due to its resistance to treatments, complicated tumor microenvironment, and heterogeneity, driving the need for novel radiosensitizers like TOP-0618.
- TOP-0618, a derivative of homocamptothecin, enhances cellular uptake and stability and inhibits DNA topoisomerase I to increase radiation-induced cytotoxicity in pancreatic cancer cells.
- In vitro studies demonstrated TOP-0618's potent cytotoxic effects in low micromolar concentrations on two pancreatic cancer cell lines, leading to increased radiosensitivity.
- TOP-0618 induced G2/M phase arrest in cancer cells, enhancing radiation sensitivity and promoting apoptotic pathways, crucial for improving therapeutic outcomes.
- Combining TOP-0618 with radiation in in vivo experiments suppressed tumor progression significantly, showcasing its translational potential for clinical applications.
- The study highlighted TOP-0618's ability to impede tumor growth, induce structural disruption in the tumor microenvironment, and enhance radiosensitivity for improved pancreatic cancer treatment.
- TOP-0618's capacity to modulate radiation doses may allow for better therapeutic outcomes with lower toxicity, making it a promising candidate for clinical development and future research.
- The research suggests that TOP-0618 could be integrated with other therapies like immunotherapy or chemotherapy to target multiple aspects of pancreatic cancer biology and improve patient prognosis.
- Overall, TOP-0618 emerges as a transformative agent in pancreatic cancer treatment, offering hope for more effective and personalized interventions with potential for clinical trials and future advancements.
- The study showcases the significance of translational science and the potential for TOP-0618 to redefine radiotherapy standards, providing new possibilities for patients battling pancreatic cancer.
Read Full Article
24 Likes
For uninterrupted reading, download the app